Nifidipine may be most effective intervention for stable angina
Published: 2004-10-20 06:58:00
Updated: 2004-10-20 06:58:00
Data presented at the October 16 Asia-Pacific symposium in Seoul showed that Bayer's Adalat (nifedipine) reduces the risk of coronary artery disease, explained Professor George Nole from the University of Zurich, department of cardiology.
Citing the long-term clinical outcome of a large study ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
